Orchard Therapeutics (ORTX)
NASDAQ: ORTX
· Real-Time Price · USD
16.70
0.05 (0.30%)
At close: Jan 23, 2024, 10:00 PM
Orchard Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 23.47M | 38.27M | 61.49M | 68.42M | 80.75M | 53.47M | 60.77M | 55.91M | 74.32M | 99.93M | 78.88M |
Short-Term Investments | 101.94M | 112.47M | 84.83M | 75.33M | 65.8M | 117.42M | 138.24M | 164.19M | 179.82M | 169.38M | 219.54M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.1M | n/a | n/a | n/a |
Other Long-Term Assets | 17.89M | 18.71M | 17.25M | 8.92M | 20.37M | 18.91M | 13.38M | 7.67M | 28.43M | 28.11M | 27.4M |
Receivables | 14.42M | 18.07M | 8.11M | 14.41M | 19.11M | 18.75M | 21.01M | 36.72M | 25.02M | 21.81M | 20.42M |
Inventory | 6.64M | 6.94M | 5.55M | 3.4M | 2.33M | 1.92M | 1.8M | 2.02M | 1.71M | 1.56M | 1.18M |
Other Current Assets | 7.45M | 5.54M | 19.89M | 9.99M | 11.26M | 13.76M | 15.62M | 53.73M | 10.59M | 11.5M | 8.4M |
Total Current Assets | 153.92M | 181.29M | 166.2M | 168.15M | 179.25M | 205.32M | 237.44M | 275.32M | 291.46M | 304.19M | 328.42M |
Property-Plant & Equipment | 27.13M | 28.83M | 30.05M | 30.91M | 30.94M | 31.19M | 31.82M | 29.08M | 31.02M | 32.46M | 33.29M |
Goodwill & Intangibles | 3.32M | 3.47M | 3.52M | 3.56M | 3.49M | 3.74M | 3.99M | 4.15M | 4.74M | n/a | n/a |
Total Long-Term Assets | 48.34M | 51.01M | 50.82M | 50.76M | 54.8M | 53.84M | 54.07M | 47.09M | 64.19M | 60.57M | 60.69M |
Total Assets | 202.27M | 232.3M | 217.02M | 218.91M | 234.05M | 259.16M | 291.5M | 322.41M | 355.66M | 364.76M | 389.11M |
Account Payables | 3.66M | 6.95M | 8.77M | 9.32M | 6.52M | 8.8M | 9.85M | 10.01M | 6.1M | 6.52M | 7.91M |
Deferred Revenue | 742K | 752K | 634K | 959K | 1.38M | 1.15M | 889K | 346K | 1.39M | 25.55M | 24.58M |
Short-Term Debt | 14.98M | 16.03M | 15.9M | 15.85M | 14.11M | 12.17M | 10.19M | 8.12M | 8.26M | 8.24M | 14.91M |
Other Current Liabilities | 30M | 33.79M | 27.98M | 34.44M | 28.27M | 26.29M | 25.98M | 24.32M | 28.5M | 636K | 1.09M |
Total Current Liabilities | 49.38M | 57.52M | 53.29M | 60.57M | 50.27M | 48.41M | 46.91M | 42.79M | 44.24M | 40.95M | 48.48M |
Long-Term Debt | 32.84M | 34.48M | 37.37M | 42.24M | 44.35M | 47.72M | 50.61M | 51.36M | 52.59M | 53.28M | 39.05M |
Other Long-Term Liabilities | 8.38M | 8.17M | 13.92M | 7.52M | 6.63M | 6.47M | 6.78M | 5.78M | 6.03M | 6.15M | 5.99M |
Total Long-Term Liabilities | 72.63M | 65.74M | 62.08M | 60.08M | 60.08M | 64.48M | 68.95M | 69.67M | 70.11M | 59.43M | 45.05M |
Total Liabilities | 122.01M | 123.25M | 115.36M | 120.64M | 110.35M | 112.89M | 115.86M | 112.46M | 114.36M | 100.38M | 93.53M |
Total Debt | 47.82M | 50.51M | 53.27M | 58.09M | 58.45M | 59.89M | 60.8M | 59.48M | 60.84M | 61.52M | 53.96M |
Common Stock | 29.46M | 29.46M | 23.87M | 16.42M | 16.37M | 16.35M | 16.28M | 16.25M | 16.23M | 16.01M | 15.99M |
Retained Earnings | -965.92M | -930.6M | -918.3M | -900.88M | -893M | -845.44M | -794.52M | -750.22M | -713.88M | -677.43M | -640.82M |
Comprehensive Income | 22.61M | 18.55M | 20.36M | 26.02M | 47.57M | 26.03M | 8.58M | 3.25M | 3.73M | -186K | 196K |
Shareholders Equity | 80.26M | 109.05M | 101.66M | 98.26M | 123.7M | 146.27M | 175.65M | 209.95M | 241.3M | 264.37M | 295.58M |
Total Investments | 101.94M | 112.47M | 84.83M | 75.33M | 65.8M | 117.42M | 138.24M | 164.19M | 179.82M | 169.38M | 219.54M |